Skip to main content
DNA Labs India

HSPD1 Gene Leukodystrophy hypomyelinating type 4 NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

HSPD1 Gene Leukodystrophy hypomyelinating type 4 NGS Genetic Test

Short Name: HSPD1 NGS Genetic Test

Also known as: HSPD1 Gene Mutation Analysis, Hypomyelinating Leukodystrophy Type 4 Genetic Test, HSP60 Gene Sequencing

HSPD1 Gene Leukodystrophy hypomyelinating type 4 NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next Generation Sequencing (NGS) on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in 3 to 4 weeks after the laboratory receives the sample.. Free home collection in 300+ cities across India.

NGS Genetic TestAll Ages🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of this test is to confirm or exclude a diagnosis of leukodystrophy hypomyelinating type 4 by identifying pathogenic mutations in the HSPD1 gene. It also helps in carrier detection, family risk assessment, and reproductive planning.

Test Code
4192
ICD Code
G31.89
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
3 to 4 weeks after the laboratory receives the sample.
Fasting Required
No
Method
Next Generation Sequencing (NGS)
Step 1

Sample Collection

No fasting is required. A physician’s referral or genetic counseling is recommended prior to testing. Patient must provide written informed consent for genetic testing.

Method: Peripheral blood draw or Fingerstick blood spot

Step 2

Laboratory Analysis

Blood is drawn from a peripheral vein or collected via a fingerstick onto an FTA card. For children, a smaller volume may be required.

Step 3

Report Delivery

No specific aftercare is needed. The sample is transported to the laboratory at ambient temperature for DNA extraction.

Timeline: 3 to 4 weeks after the laboratory receives the sample.

Patient Instructions

1
Before the Test:Discuss with your doctor if you have a family history of leukodystrophy or if your child shows developmental delays. Provide all medical records and MRI reports to the genetic counselor.
2
During the Test:The test involves a simple blood draw. There is no injection of any special substance. The process takes a few minutes.
3
After the Test:After the test, you will receive regular updates on the sample status. The report will be shared online once analysis is complete. You will have access to a genetic counselor for discussing the results.

About This Test

Who Should Get This Test

The purpose of this test is to confirm or exclude a diagnosis of leukodystrophy hypomyelinating type 4 by identifying pathogenic mutations in the HSPD1 gene. It also helps in carrier detection, family risk assessment, and reproductive planning.

How to Prepare

  • Inform your doctor about any anticoagulant medications.
  • Avoid blood transfusion for at least 72 hours prior to sample collection.
  • For FTA card, ensure the spots are saturated and dried completely.
  • Label the sample correctly with patient identifier and date of birth.

Doctor's Notes

Reviewed by — MBBS, MD (General Medicine) · Reg. No. 8052

"In my practice, I recommend HSPD1 NGS testing for pediatric patients with unexplained hypomyelination on MRI. Early genetic confirmation can guide patient management and family planning."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
Sample Volume3-5 ml blood
ContainerEDTA vial (whole blood) / FTA card
Collection MethodPeripheral blood draw or Fingerstick blood spot

Sample Stability

Whole blood (EDTA): 5-7 days at 4°C
FTA card: stable at room temperature for many years
Extracted DNA: stable at -20°C for months
Sample Rejection Criteria:
  • Insufficient blood volume or FTA spots
  • Haemolysed or clotted sample
  • Unlabelled or mislabeled sample
  • Sample in non-EDTA tube containing heparin (inhibits PCR)

Understanding Your Results

The HSPD1 NGS genetic test report identifies the presence or absence of pathogenic variants in the HSPD1 gene. Results should be interpreted by a clinical geneticist or a qualified healthcare provider.
Positive: A pathogenic or likely pathogenic variant in HSPD1 confirms the diagnosis of leukodystrophy hypomyelinating type 4 (HLD4).
Negative: No pathogenic variant was detected. If clinical suspicion is high, consider whole exome sequencing or other leukodystrophy panels.
Variant of Uncertain Significance (VUS): A genetic variant was identified but its clinical significance is unknown. Further family studies may be needed to clarify inheritance.
⚠️ When to Consult a Doctor:

Consult a neurologist or clinical geneticist if the test is positive, if symptoms persist despite a negative result, or if you are planning a family and are known to carry an HSPD1 mutation.

Limitations

  • This test detects point mutations and small indels in the HSPD1 coding regions and splice junctions. It does not detect large deletions, duplications, or deep intronic variants without functional impact.
  • Variant classification may be uncertain for novel or rare variants.
  • Results are interpreted in the context of the patient's clinical presentation and family history.

Risks & Considerations

  • Minor bruising at the blood draw site
  • Dizziness or faintness during blood draw
  • Psychological stress from a potentially positive genetic result

Interfering Factors

  • Sample contamination or low DNA concentration
  • Mosaicism below analytical sensitivity
  • Consanguinity in the family may complicate segregation analysis
  • Very rare large deletions/duplications may not be detected by standard NGS bioinformatics pipelines

Compare With Similar Tests

TestHSPD1 Gene Leukodystrophy hypomyelinating type 4 NGS Genetic TestHSPD1 NGS Genetic TestLeukodystrophy NGS PanelWhole Exome Sequencing
ComparisonHSPD1 Gene Leukodystrophy hypomyelinating type 4 NGS Genetic Test

Frequently Asked Questions

What is the cost of the HSPD1 gene leukodystrophy hypomyelinating type 4 NGS genetic test?
The test costs INR 20,000 in India. DNA Labs India offers this test at a discounted price of ?20,000 with free home sample collection across more than 200 cities.
What is the sample requirement for this test?
The test requires a blood sample (3–5 ml in an EDTA vial), or extracted DNA, or a single drop of blood on an FTA card. No fasting is required.
How long does it take to get the report?
The turnaround time is 3 to 4 weeks, as next-generation sequencing and bioinformatics analysis take time. You will receive the report online by email or WhatsApp.
What does the test detect?
This NGS genetic test detects mutations in the HSPD1 gene that cause leukodystrophy hypomyelinating type 4 (HLD4). It identifies single nucleotide variants, small insertions/deletions, and splice-site changes in the HSPD1 coding region.
Why is NGS technology used?
NGS (Next Generation Sequencing) allows high-throughput, accurate sequencing of the entire HSPD1 gene in a single assay. It is more sensitive and comprehensive than traditional Sanger sequencing for detecting point mutations.
Is the test covered by insurance?
Coverage varies by insurer and policy. It is recommended to check with your insurance provider. DNA Labs India does not claim insurance approval.
Can this test be done on a pregnant woman or for prenatal diagnosis?
Prenatal testing for HLD4 is possible through chorionic villus sampling or amniocentesis after genetic counseling and confirmation of the familial mutation. This test is not automatically performed prenatally.
What is leukodystrophy hypomyelinating type 4?
It is a rare inherited neurological disorder caused by mutations in the HSPD1 gene that lead to defective myelin formation in the central nervous system. Symptoms include developmental delay, spasticity, ataxia, and seizures.
Is a referral from a doctor required?
While we accept self-referrals, we strongly recommend that the test be ordered by a neurologist or clinical geneticist. Pretest genetic counseling is recommended to draw a family pedigree and discuss implications.
Do I get the raw data files with the report?
Yes, DNA Labs India is transparent in reporting. Along with the clinical report, you will receive raw data files in FASTQ and VCF formats for HSPD1 gene sequencing. This allows independent reanalysis if needed.
What is the difference between a clinical report and raw data?
The clinical report provides a physician-interpreted summary of detected variants, classification, and medical recommendations. Raw data (FASTQ/VCF) are the actual sequencing data files that can be used for secondary bioinformatics analysis.
What is the specialty of the author and physician reviewing this test?
The content is reviewed by a clinical geneticist (author) and an obstetrics & gynecology specialist with expertise in genetic counseling (physician), ensuring comprehensive and accurate information.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.